
UnitedHealth Group Incorporated: shareholders and insiders
Price
$339.85
November 20, 2026Market cap $308B
What Ploutos Investor adds for UnitedHealth
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 21, 2025 to Nov 13, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$944.9K
1 person
From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 21, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $944.9K by 1 person
- 2025: no buys, no sales
- 2026: no buys, sold $944.9K by 1 person
- Nov 11, 2026Timothy John NoelChief Executive Officer, UHCKind
- Oct 1, 2026John H NoseworthyDirectorKind
- Oct 1, 2026Rice Valerie Md MontgomeryDirectorKind
- Oct 1, 2026Frederick William Mcnabb IiiDirectorKind
- Oct 1, 2026Scott GottliebDirectorKind
- Oct 1, 2026Kristen GilDirectorKind
- Oct 1, 2026Paul R GarciaDirectorKind
- Oct 1, 2026Paul R GarciaDirectorKind
- Oct 1, 2026Timothy Patrick FlynnDirectorKind
- Oct 1, 2026Charles D. BakerDirectorKind
- Sep 22, 2026Frederick William Mcnabb IiiDirectorKind
- Sep 22, 2026Dennis Andrew StankiewiczChief Accounting OfficerKind
- Sep 22, 2026Charles D. BakerDirectorKind
- Sep 22, 2026Timothy Patrick FlynnDirectorKind
- Sep 22, 2026John H NoseworthyDirectorKind
- Sep 22, 2026Scott GottliebDirectorKind
- Sep 22, 2026Christopher R ZaettaEVP & Chief Legal OfficerKind
- Sep 22, 2026Stephen J HemsleyCEO, UHGKind
- Sep 22, 2026Rice Valerie Md MontgomeryDirectorKind
- Sep 22, 2026Paul R GarciaDirectorKind
- Sep 22, 2026Kristen GilDirectorKind
- Sep 22, 2026Patrick Hugh ConwayChief Executive Officer, OptumKind
- Sep 22, 2026Wayne S DeVeydtChief Financial OfficerKind
- Sep 22, 2026Timothy John NoelChief Executive Officer, UHCKind
- Sep 22, 2026Erin McSweeneyEVP & Chief People OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Timothy John NoelChief Executive Officer, UHC | 587 | $402.94 | $236.3K | Form 4 | |
| Oct 1, 2026 | John H NoseworthyDirector | 240 | – | – | Form 4 | |
| Oct 1, 2026 | Rice Valerie Md MontgomeryDirector | 257 | – | – | Form 4 | |
| Oct 1, 2026 | Frederick William Mcnabb IiiDirector | 291 | – | – | Form 4 | |
| Oct 1, 2026 | Scott GottliebDirector | 257 | – | – | Form 4 | |
| Oct 1, 2026 | Kristen GilDirector | 240 | – | – | Form 4 | |
| Oct 1, 2026 | Paul R GarciaDirector | 155 | – | – | Form 4 | |
| Oct 1, 2026 | Paul R GarciaDirector | 103 | – | – | Form 4 | |
| Oct 1, 2026 | Timothy Patrick FlynnDirector | 262 | – | – | Form 4 | |
| Oct 1, 2026 | Charles D. BakerDirector | 257 | – | – | Form 4 | |
| Sep 22, 2026 | Frederick William Mcnabb IiiDirector | 57 | – | – | Form 4 | |
| Sep 22, 2026 | Dennis Andrew StankiewiczChief Accounting Officer | 51 | – | – | Form 4 | |
| Sep 22, 2026 | Charles D. BakerDirector | 15 | – | – | Form 4 | |
| Sep 22, 2026 | Timothy Patrick FlynnDirector | 68 | – | – | Form 4 | |
| Sep 22, 2026 | John H NoseworthyDirector | 46 | – | – | Form 4 | |
| Sep 22, 2026 | Scott GottliebDirector | 5 | – | – | Form 4 | |
| Sep 22, 2026 | Christopher R ZaettaEVP & Chief Legal Officer | 67 | – | – | Form 4 | |
| Sep 22, 2026 | Stephen J HemsleyCEO, UHG | 50 | – | – | Form 4 | |
| Sep 22, 2026 | Rice Valerie Md MontgomeryDirector | 47 | – | – | Form 4 | |
| Sep 22, 2026 | Paul R GarciaDirector | 16 | – | – | Form 4 | |
| Sep 22, 2026 | Kristen GilDirector | 10 | – | – | Form 4 | |
| Sep 22, 2026 | Patrick Hugh ConwayChief Executive Officer, Optum | 91 | – | – | Form 4 | |
| Sep 22, 2026 | Wayne S DeVeydtChief Financial Officer | 106 | – | – | Form 4 | |
| Sep 22, 2026 | Timothy John NoelChief Executive Officer, UHC | 84 | – | – | Form 4 | |
| Sep 22, 2026 | Erin McSweeneyEVP & Chief People Officer | 53 | – | – | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 4, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by UNH's officers and directors from 2006 up to November 20, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 27, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Tiger Global (Coleman)In the quarter
- Renaissance TechnologiesIn the quarter+507%
- Citadel Advisors (Griffin)In the quarter+91%
- Millennium Mgmt (Englander)In the quarter-23%
- AQR CapitalIn the quarter-2.6%
- Point72 (Cohen)In the quarter-69%
- D.E. ShawIn the quarter-13%
- Bridgewater (Dalio)In the quarter+734%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Tiger Global (Coleman) | 297.5K | $109M | 0.54% | |
| Renaissance Technologies | 2.23M | +507% | $817M | 1.11% |
| Citadel Advisors (Griffin) | 2.04M | +91% | $747M | 0.41% |
| Millennium Mgmt (Englander) | 1.24M | -23% | $456M | 0.33% |
| AQR Capital | 1.71M | -2.6% | $628M | 0.19% |
| Point72 (Cohen) | 253.9K | -69% | $93M | 0.15% |
| D.E. Shaw | 428.8K | -13% | $157M | 0.10% |
| Bridgewater (Dalio) | 51.7K | +734% | $19M | 0.08% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short sales in daily trading
How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.
In the last 14 sessions, 31.1% of the shares in the reported trades were short sales, against 43.7% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 31.1%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 43.7%
- Change
- -12.6 pts
- Short sales a dayon average, of 3.18M shares
- 989.7K
- More than atof 3,666 US-listed companies, same days
- 6%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 43.6%
- Oct 15, 2026: Short sales 55.6%
- Oct 16, 2026: Short sales 46.2%
- Oct 19, 2026: Short sales 48.7%
- Oct 20, 2026: Short sales 45.4%
- Oct 21, 2026: Short sales 54%
- Oct 22, 2026: Short sales 47.3%
- Oct 23, 2026: Short sales 43.7%
- Oct 26, 2026: Short sales 36.8%
- Oct 27, 2026: Short sales 40.5%
- Oct 28, 2026: Short sales 49.4%
- Oct 29, 2026: Short sales 38.2%
- Oct 30, 2026: Short sales 34.2%
- Nov 2, 2026: Short sales 20.4%
- Nov 3, 2026: Short sales 41.1%
- Nov 4, 2026: Short sales 40.2%
- Nov 5, 2026: Short sales 32.4%
- Nov 6, 2026: Short sales 29.8%
- Nov 9, 2026: Short sales 42.5%
- Nov 10, 2026: Short sales 41.7%
- Nov 11, 2026: Short sales 32%
- Nov 12, 2026: Short sales 33.1%
- Nov 13, 2026: Short sales 53.6%
- Nov 16, 2026: Short sales 49.1%
- Nov 17, 2026: Short sales 42.9%
- Nov 18, 2026: Short sales 26.2%
- Nov 19, 2026: Short sales 14%
- Nov 20, 2026: Short sales 30.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Stephen J HemsleyCEO, UHGDirectly1.06M
- John F RexPresident & CFODirectly203.8K
- Thomas E RoosChief Accounting OfficerDirectly29.5K
- Brian R ThompsonCEO, UnitedHealthcareDirectly25.5K
- Wayne S DeVeydtChief Financial OfficerDirectly18.7K
- Timothy Patrick FlynnDirectorDirectly11.2K
- Timothy John NoelChief Executive Officer, UHCDirectly17.1K
- Christopher R ZaettaEVP & Chief Legal OfficerDirectly15.9K
- Frederick William Mcnabb IiiDirectorDirectly15.8K
- Erin McSweeneyEVP & Chief People OfficerDirectly15.7K
- Patrick Hugh ConwayChief Executive Officer, OptumDirectly15.4K
- Dennis Andrew StankiewiczChief Accounting OfficerDirectly10.1K
- Rice Valerie Md MontgomeryDirectorDirectly8,180
- John H NoseworthyDirectorDirectly7,902
- Kristen GilDirectorDirectly2,849
- Paul R GarciaDirectorDirectly6,426
- Charles D. BakerDirectorDirectly2,668
- Scott GottliebDirectorDirectly921
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Stephen J HemsleyCEO, UHG | 1.06M | – | Sep 22, 2026 | Form 4 |
| John F RexPresident & CFO | 203.8K | – | May 16, 2025 | Form 4 |
| Thomas E RoosChief Accounting Officer | 29.5K | – | Jul 17, 2024 | Form 4 |
| Brian R ThompsonCEO, UnitedHealthcare | 25.5K | – | Feb 16, 2024 | Form 4 |
| Wayne S DeVeydtChief Financial Officer | 18.7K | – | Sep 22, 2026 | Form 4 |
| Timothy Patrick FlynnDirector | 11.2K | 6,033 | Oct 1, 2026 | Form 4 |
| Timothy John NoelChief Executive Officer, UHC | 17.1K | – | Nov 11, 2026 | Form 4 |
| Christopher R ZaettaEVP & Chief Legal Officer | 15.9K | – | Sep 22, 2026 | Form 4 |
| Frederick William Mcnabb IiiDirector | 15.8K | – | Oct 1, 2026 | Form 4 |
| Erin McSweeneyEVP & Chief People Officer | 15.7K | – | Sep 22, 2026 | Form 4 |
| Patrick Hugh ConwayChief Executive Officer, Optum | 15.4K | – | Sep 22, 2026 | Form 4 |
| Dennis Andrew StankiewiczChief Accounting Officer | 10.1K | – | Sep 22, 2026 | Form 4 |
| Rice Valerie Md MontgomeryDirector | 8,180 | – | Oct 1, 2026 | Form 4 |
| John H NoseworthyDirector | 7,902 | – | Oct 1, 2026 | Form 4 |
| Kristen GilDirector | 2,849 | 3,818 | Oct 1, 2026 | Form 4 |
| Paul R GarciaDirector | 6,426 | – | Oct 1, 2026 | Form 4 |
| Charles D. BakerDirector | 2,668 | – | Oct 1, 2026 | Form 4 |
| Scott GottliebDirector | 921 | – | Oct 1, 2026 | Form 4 |
A lower bound: it counts only the 18 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$25M
Actually paid: -$7.1M
$61M
Actually paid: $56M
$19M
Actually paid: $13M
$102
Peers: $148
Adjusted EPS
- 2025CEO pay$86M$100 in the stock$102Peers: $148
- 2024CEO pay$26M$100 in the stock$153Peers: $129
- 2023CEO pay$24M$100 in the stock$157Peers: $126
| Year | CEO pay | Actually paid | Other officers, average | $100 in the stock |
|---|---|---|---|---|
| 2025 | $86M | $49M | $19M | $102Peers: $148 |
| 2024 | $26M | $24M | $10M | $153Peers: $129 |
| 2023 | $24M | $20M | $12M | $157Peers: $126 |
Executive pay
UNH's executive pay against its returns, from 2020 to 2022, 3 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
From the proxy statement (DEF 14A) of Apr 21, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Jun 30, 202510-QAmount$2.5B
- Mar 31, 202510-QAmount$3.0B
- Dec 31, 202410-KAmount$4.9B
- Sep 30, 202410-QAmount$926M
- Mar 31, 202410-QAmount$3.1B
- Dec 31, 202310-KAmount$1.5B
- Sep 30, 202310-QAmount$1.5B
- Jun 30, 202310-QAmount$3.0B
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Jun 30, 202510-Q | 6.10M | $407.06 | $2.5B | 21.00M shares | 10-Q |
| Mar 31, 202510-Q | 6.00M | $503.72 | $3.0B | 27.10M shares | 10-Q |
| Dec 31, 202410-K | 9.10M | $537.14 | $4.9B | 33.10M shares | 10-K |
| Sep 30, 202410-Q | 577M | $1.60 | $926M | 42.20M shares | 10-Q |
| Mar 31, 202410-Q | 6.10M | $505.46 | $3.1B | 8.80M shares | 10-Q |
| Dec 31, 202310-K | 2.80M | $535.34 | $1.5B | 14.90M shares | 10-K |
| Sep 30, 202310-Q | 3.10M | $489.56 | $1.5B | 17.70M shares | 10-Q |
| Jun 30, 202310-Q | 6.20M | $483.07 | $3.0B | 20.80M shares | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 2 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026Jun 5, 2026For82.6%
- 2025Jun 4, 2025For60.1%
- 2024Jun 7, 2024For96.2%
- 2023Jun 9, 2023For95.8%
- 2022Jun 10, 2022For94.1%
- 2021Jun 11, 2021For72.7%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026Jun 5, 2026 | 82.6% | 559M | 118M | 1.16M | 89.74M | 8-K |
| 2025Jun 4, 2025 | 60.1% | 451M | 299M | 1.69M | 59.84M | 8-K |
| 2024Jun 7, 2024 | 96.2% | 730M | 29.08M | 1.90M | 64.51M | 8-K |
| 2023Jun 9, 2023 | 95.8% | 745M | 32.64M | 2.27M | 62.03M | 8-K |
| 2022Jun 10, 2022 | 94.1% | 737M | 46.18M | 1.31M | 58.80M | 8-K |
| 2021Jun 11, 2021 | 72.7% | 577M | 217M | 1.39M | 58.89M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund21.91%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund6.57%
- IYHiShares U.S. Healthcare ETFWeight in the fund6.16%
- VHTVanguard Health Care Index FundWeight in the fund4.90%
- DIADIAWeight in the fund4.69%
- IXJiShares Global Healthcare ETFWeight in the fund4.40%
- SCHDSchwab U.S. Dividend Equity ETFWeight in the fund3.82%
- DGRWWisdomTree U.S. Quality Dividend Growth FundWeight in the fund2.92%
- QLTYGMO U.S. Quality ETFWeight in the fund2.53%
- PVALPutnam Focused Large Cap Value ETFWeight in the fund2.23%
71 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 3,172
- Q4 2025: Managers 3,313
- Q1 2026: Managers 3,054
- Q2 2026: Managers 3,378
Institutional investors by quarter
The fund managers holding UNH, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 3,378 managers held 787M shares, worth $326B. During the quarter 521 opened a position, 197 closed one, 1,286 added and 1,237 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+4.6%
- Vanguard Capital ManagementIn the quarter+0.7%
- State StreetIn the quarter+0.7%
- Capital World InvestorsIn the quarter+7.6%
- FMRIn the quarter+133%
- Vanguard Portfolio ManagementIn the quarter+1.9%
- Price T Rowe AssociatesIn the quarter+11%
- Geode Capital ManagementIn the quarter-4.5%
- JPMorgan ChaseIn the quarter+6.0%
- Charles Schwab Investment ManagementIn the quarter-4.7%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 76.86M | +4.6% | $31.9B |
| Vanguard Capital Management | 59.31M | +0.7% | $24.7B |
| State Street | 45.63M | +0.7% | $19.0B |
| Capital World Investors | 29.89M | +7.6% | $12.4B |
| FMR | 27.99M | +133% | $11.6B |
| Vanguard Portfolio Management | 24.48M | +1.9% | $10.2B |
| Price T Rowe Associates | 23.15M | +11% | $9.6B |
| Geode Capital Management | 21.75M | -4.5% | $9.0B |
| JPMorgan Chase | 20.25M | +6.0% | $8.5B |
| Charles Schwab Investment Management | 19.83M | -4.7% | $8.2B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do UnitedHealth's filings show?
Who buys and sells is one part of UnitedHealth's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have UNH's insiders bought or sold?
From Jun 4, 2026 to Nov 13, 2026 UnitedHealth's insiders bought 0 and sold $660.9K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold UNH?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $817M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.